Invictus RG lifted its holdings in shares of Halyard Health Inc (NYSE:HYH) by 605.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,504 shares of the medical instruments supplier’s stock after buying an additional 6,440 shares during the quarter. Invictus RG’s holdings in Halyard Health were worth $347,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of the company. Jarislowsky Fraser Ltd bought a new position in Halyard Health in the third quarter valued at approximately $200,000. Jane Street Group LLC bought a new stake in shares of Halyard Health in the third quarter worth $211,000. Raymond James Financial Services Advisors Inc. bought a new stake in shares of Halyard Health in the second quarter worth $217,000. Ramsey Quantitative Systems bought a new stake in shares of Halyard Health in the fourth quarter worth $266,000. Finally, Crossmark Global Holdings Inc. bought a new stake in shares of Halyard Health in the third quarter worth $280,000. Institutional investors own 91.34% of the company’s stock.
HYH has been the topic of several analyst reports. Zacks Investment Research lowered shares of Halyard Health from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. ValuEngine upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a report on Wednesday, February 28th. Finally, TheStreet upgraded shares of Halyard Health from a “c+” rating to a “b” rating in a report on Monday, December 4th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $49.33.
Halyard Health Inc (HYH) traded down $0.95 on Wednesday, reaching $46.63. 493,313 shares of the company traded hands, compared to its average volume of 345,868. The company has a market capitalization of $2,308.47, a PE ratio of 27.92, a price-to-earnings-growth ratio of 5.76 and a beta of 1.60. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.98 and a quick ratio of 2.74. Halyard Health Inc has a 1-year low of $35.24 and a 1-year high of $50.99.
Halyard Health (NYSE:HYH) last posted its earnings results on Tuesday, February 27th. The medical instruments supplier reported $0.73 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.23. The firm had revenue of $428.10 million during the quarter, compared to analysts’ expectations of $413.94 million. Halyard Health had a net margin of 5.82% and a return on equity of 6.98%. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.50 earnings per share. sell-side analysts anticipate that Halyard Health Inc will post 0.96 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Halyard Health Inc (NYSE:HYH) Holdings Increased by Invictus RG” was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://ledgergazette.com/2018/03/14/halyard-health-inc-hyh-holdings-boosted-by-invictus-rg.html.
About Halyard Health
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.